ABL
Pharmaceutical ManufacturingView the employees at
ABL-
Moustapha Diop Contrôleur de gestion / Comptable chez ABL Europe
-
Greater Strasbourg Metropolitan Area
-
Top 10%
Damien CARLI Technien contrôle qualite chez ABL Europe-
Villeurbanne, Auvergne-Rhône-Alpes, France
-
Rising Star
joachim Gutierrez Process Development & Biomanufacturing Engineer at ABL Europe-
France
-
Rising Star
Séverine GRAEFF-LAMBOLEY QA Manager chez ABL Europe-
Greater Strasbourg Metropolitan Area
-
Rising Star
Fabien Reichert Superviseur chaîne logistique chez ABL Europe-
Strasbourg, Grand Est, France
-
Rising Star
Overview
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.
-